Apheresis therapy in children: an overview of key technical aspects and a review of experience in pediatric renal disease (Q38082735)

28 August 2017

title

Apheresis therapy in children: an overview of key technical aspects and a review of experience in pediatric renal disease (English)

1 reference

28 August 2017

Elizabeth A K Hunt

1 reference

28 August 2017

Namrata G Jain

series ordinal

1 reference

28 August 2017

Michael J G Somers

series ordinal

1 reference

28 August 2017

publication date

1 February 2013

1 reference

Journal of Clinical Apheresis

28 August 2017

published in

1 reference

28 August 2017

1 reference

28 August 2017

1 reference

28 August 2017

page(s)

36-47

1 reference

Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis

28 August 2017

cites work

1 reference

Pediatric therapeutic plasma exchange indications and patterns of use in US children's hospitals

21 January 2018

1 reference

Therapeutic pediatric apheresis

21 January 2018

1 reference

Central venous catheters for apheresis access

21 January 2018

1 reference

Vascular access in children

21 January 2018

1 reference

Complications of apheresis in children.

21 January 2018

1 reference

An overview of therapeutic apheresis in pediatrics

21 January 2018

1 reference

Adverse reactions associated with mobile therapeutic apheresis: analysis of 17,940 procedures

21 January 2018

1 reference

Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

21 January 2018

1 reference

Single-center analysis of early recurrence of nephrotic syndrome following renal transplantation in children

21 January 2018

1 reference

Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis

21 January 2018

1 reference

Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients

21 January 2018

1 reference

Long-term outcome of focal segmental glomerulosclerosis after pediatric renal transplantation

21 January 2018

1 reference

A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children

21 January 2018

1 reference

Incidence of Wegener's granulomatosis in children

21 January 2018

1 reference

Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis

21 January 2018

1 reference

A case of a 6-year-old girl with anti-neutrophil cytoplasmic autoantibody-negative pauci-immune crescentic glomerulonephritis

21 January 2018

1 reference

Antineutrophil cytoplasm antibody in crescentic glomerulonephritis

21 January 2018

1 reference

Childhood vasculitis and plasma exchange

21 January 2018

1 reference

Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression.

21 January 2018

1 reference

Clinical spectrum and outcome of crescentic glomerulonephritis in children in developing countries

21 January 2018

1 reference

The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings

21 January 2018

1 reference

Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS).

21 January 2018

1 reference

Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression

21 January 2018

1 reference

Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome

21 January 2018

1 reference

Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome

21 January 2018

1 reference

Atypical hemolytic uremic syndrome

21 January 2018

1 reference

A case of atypical hemolytic uremic syndrome due to anti-factor H antibody in a patient presenting with a factor XII deficiency identified two novel mutations

21 January 2018

1 reference

Plasma therapy for atypical haemolytic uraemic syndrome associated with heterozygous factor H mutations

21 January 2018

1 reference

Complement factor H-associated atypical hemolytic uremic syndrome in monozygotic twins: concordant presentation, discordant response to treatment

21 January 2018

1 reference

Challenges in the management of infantile factor H associated hemolytic uremic syndrome.

21 January 2018

1 reference

Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome

21 January 2018

1 reference

Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome.

21 January 2018

1 reference

Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial

21 January 2018

1 reference

Treatment of the childhood haemolytic uraemic syndrome with plasma. A multicentre randomized controlled trial. The French Society of Paediatric Nephrology

21 January 2018

1 reference

An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children

21 January 2018

1 reference

Desensitization in HLA-incompatible kidney recipients and survival

21 January 2018

1 reference

Rituximab and intravenous immune globulin for desensitization during renal transplantation

21 January 2018

1 reference

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

21 January 2018

1 reference

Desensitization protocol in highly HLA-sensitized and ABO-incompatible high titer kidney transplantation

21 January 2018

1 reference

Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.

21 January 2018

1 reference

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

21 January 2018

1 reference

Banff 2011 Meeting report: new concepts in antibody-mediated rejection

21 January 2018

1 reference

A retrospective review of the outcome of plasma exchange and aggressive medical therapy in antibody mediated rejection of renal allografts: a single center experience

21 January 2018

1 reference

Long-term experience of plasmapheresis in antibody-mediated rejection in renal transplantation

21 January 2018

1 reference

Plasmapheresis and intravenous immunoglobulin in early antibody-mediated rejection of the renal allograft: a single-center experience

21 January 2018

1 reference

Impact of rituximab therapy for treatment of acute humoral rejection

21 January 2018

1 reference

Plasmapheresis as rescue therapy in accelerated acute humoral rejection

21 January 2018

1 reference

Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation

21 January 2018

1 reference

Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection

21 January 2018

1 reference

Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection.

21 January 2018

1 reference

Prevention and treatment of alloantibody-mediated kidney transplant rejection

21 January 2018

1 reference

Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation

21 January 2018

1 reference

Kidney transplantation after desensitization in sensitized patients: a Korean National Audit

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCA.21260

1 reference

28 August 2017

1 reference